by Caroline Wallace, Medical University of South Carolina Brian Hess, M.D., a Hollings researcher, and lymphoma specialist was key in bringing a phase 2 lymphoma clinical trial to Hollings. Credit: MUSC HollingsEmma C. Vought MUSC Hollings Cancer Center was one of 28 clinical sites around the world that participated in the LOTIS-2 trial to test the...
